These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A single unit lymphoma experience: outcome in a Cape Town academic centre. Wood L; Robinson R; Gavine L; Juritz J; Jacobs P Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976 [TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
7. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Haas RL; Poortmans P; de Jong D; Verheij M; van der Hulst M; de Boer JP; Bartelink H Eur J Cancer; 2005 Aug; 41(12):1724-30. PubMed ID: 16039113 [TBL] [Abstract][Full Text] [Related]
8. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma. Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365 [TBL] [Abstract][Full Text] [Related]
9. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma. Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382 [TBL] [Abstract][Full Text] [Related]
10. [Primary gastric lymphoma]. Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686 [TBL] [Abstract][Full Text] [Related]
11. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
12. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint]. Meusers P; Brittinger G Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome. Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321 [TBL] [Abstract][Full Text] [Related]
14. International prognostic index-based outcomes for diffuse large B-cell lymphomas. Wilder RB; Rodriguez MA; Medeiros LJ; Tucker SL; Ha CS; Romaguera JE; Pro B; Hess MA; Cabanillas F; Cox JD Cancer; 2002 Jun; 94(12):3083-8. PubMed ID: 12115338 [TBL] [Abstract][Full Text] [Related]
15. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003. Jezersek Novaković B; Vovk M; Juznic Setina T Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146 [TBL] [Abstract][Full Text] [Related]
16. Lymphoma of the ocular adnexa: A study of 353 cases. Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761 [TBL] [Abstract][Full Text] [Related]
17. Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3. Cuttica A; Zallio F; Ladetto M; Di Nicola M; Caracciolo D; Magni M; Marinone C; Dell'Aquila M; Rosace M; Pileri A; Boccadoro M; Gianni AM; Tarella C Cancer; 2003 Sep; 98(5):983-92. PubMed ID: 12942566 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054 [TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital. Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]